Stomach
Serum derived bovine immunoglobulin/protein isolate
Acid secretion inhibitors
Other names: EnteraGam
FAA guidance
Acceptable in the FAA document cited.
The FAA's MedGuide lists serum derived bovine immunoglobulin/protein isolate (EnteraGam) as allowed, for irritable bowel syndrome (IBS), with no wait after the first dose, after later doses or after the final dose, used as prescribed.
Track your medicationsMore detail: serum derived bovine immunoglobulin/protein isolateThe rest of Crosscheck's reading, in plain wordsOpen
The MedGuide defines allowed as acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present, and says wait times are not determined solely by the medication: an extended observation period may be required to verify clinical stability of the condition.
Show the FAA's words: serum derived bovine immunoglobulin/protein isolateThe official FAA wording: three passages, each with its document and dateOpen
Generic: serum derived bovine immunoglobulin/protein isolate
Brand Name: EnteraGam
Drug Class: Acid secretion inhibitors
Underlying Condition: Irritable bowel syndrome (IBS)
Use: ALLOW
INITIAL Wait Time (after first dose): None
SUBSEQUENT Dose Wait Time (after each dose): None
DISCONTINUATION Wait Time (after final dose): None
Frequency Use Limit: As prescribed
ALLOWED: The medication is acceptable for use while performing flight or safety-related duties, provided the condition is stable/aeromedically acceptable and no adverse side effects are present.
Underlying Condition: Evaluating medication use requires considering the impact of safety of flight from both the medication and underlying condition. Wait times are not determined solely by the medication; an extended observation period may be required to verify clinical stability of the condition.